These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2117206)

  • 1. Early versus late surfactant replacement therapy in severe respiratory distress syndrome.
    Speer CP; Harms K; Herting E; Neumann N; Curstedt T; Robertson B
    Lung; 1990; 168 Suppl():870-6. PubMed ID: 2117206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
    Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
    Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].
    Gortner L; Bartmann P; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL; Versmold H
    Z Geburtshilfe Perinatol; 1992; 196(4):159-64. PubMed ID: 1413943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
    Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
    Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome.
    Sun H; Cheng R; Kang W; Xiong H; Zhou C; Zhang Y; Wang X; Zhu C
    Respir Care; 2014 Feb; 59(2):159-69. PubMed ID: 23764865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
    Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
    Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
    Gortner L
    J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.